Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $3.27M in the quarter ending March 31, 2026, a decrease of -45.11%. This brings the company's revenue in the last twelve months to $28.22M, up 20.08% year-over-year. In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth.

• Revenue (ttm): $28.22M
• Revenue Growth: +20.08%
• P/S Ratio: 9.86
• Revenue / Employee: $266,264
• Employees: 106
• Market Cap: 271.26M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.91M	8.31M	36.75%
Dec 31, 2024	22.60M	-11.55M	-33.83%
Dec 31, 2023	34.16M	14.93M	77.63%
Dec 31, 2022	19.23M	17.91M	1,357.77%
Dec 31, 2021	1.32M	889.00K	206.74%
Dec 31, 2020	430.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error